Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I0MR
|
|||
| Former ID |
DNC004649
|
|||
| Drug Name |
(Z)-1,1,1-Trifluoro-nonadec-10-en-2-one
|
|||
| Synonyms |
CHEMBL422064; (Z)-1,1,1-Trifluoro-nonadec-10-en-2-one; SCHEMBL8059738; C19H33F3O; MolPort-009-018-697; HMS3649G07; BDBM50069273; 1964AH; ZINC34803437; LS-96805; (Z)-1,1,1-Trifluoro-10-nonadecen-2-one; (10z)-1,1,1-trifluorononadec-10-en-2-one; SR-01000946571; SR-01000946571-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H33F3O
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C(F)(F)F
|
|||
| InChI |
1S/C19H33F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(23)19(20,21)22/h9-10H,2-8,11-17H2,1H3/b10-9-
|
|||
| InChIKey |
SOJGXPSMVNTNQL-KTKRTIGZSA-N
|
|||
| CAS Number |
CAS 177987-23-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.